IMPACT BIOMEDICAL INC. Note Agreements
14 Contracts & Agreements
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on August 20, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on June 11, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on February 28, 2024)
- Amendment to Promissory Note effective January 18, 2024 between Impact BioMedical Inc. and DSS, Inc (Filed With SEC on January 22, 2024)
- Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on October 17, 2023)
- Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on October 17, 2023)
- Revolving Promissory Note dated December 31, 2020 (Filed With SEC on October 17, 2023)
- Convertible Promissory Note dated May 14, 2021 (Filed With SEC on October 17, 2023)
- Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on October 17, 2023)
- Promissory Note with Dustin Michael Crum dated February 21, 2021 (Filed With SEC on August 24, 2022)
- Amendment No. 2 to Revolving Promissory Note dated March 31, 2022 (Filed With SEC on August 2, 2022)
- Amendment No. 1 to Revolving Promissory Note dated December 31, 2021 (Filed With SEC on August 2, 2022)
- Revolving Promissory Note dated December 31, 2020 (Filed With SEC on August 2, 2022)
- Convertible Promissory Note dated May 14, 2021 (Filed With SEC on June 24, 2022)